Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial

200937 citationsJournal Article

Authors

Good health and well-being

Published in: Wiener klinische Wochenschrift

Volume 121, Issue 23-24, pp. 765-775

Field-Weighted Citation Impact: 2.03